Modeling & Simulation

ARPA-H Is Funding In Silico Drug Testing. Its Compute Footprint Is Still Opaque.

FDA is expanding non-animal methods while ARPA-H funds human drug-safety models. Public materials omit runtime, hardware, and deployment cost.